Alzheimer's soluble amyloid beta is a normal component of human urine (Q36865008)

16 August 2017

Alzheimer's soluble amyloid beta is a normal component of human urine (English)

1 reference

16 August 2017

0 references

Ghiso J

1

1 reference

16 August 2017

Calero M

2

1 reference

16 August 2017

Matsubara E

3

1 reference

16 August 2017

Governale S

4

1 reference

16 August 2017

Chuba J

5

1 reference

16 August 2017

Beavis R

6

1 reference

16 August 2017

Wisniewski T

7

1 reference

16 August 2017

Frangione B

8

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

16 August 2017

1 reference

16 August 2017

408

1 reference

16 August 2017

1

1 reference

16 August 2017

105-108

1 reference

Alzheimer's disease and soluble A beta

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Characterization of beta-amyloid peptide from human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Apolipoprotein J and Alzheimer's amyloid beta solubility

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Blood-brain barrier transport of circulating Alzheimer's amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Characterization of apolipoprotein J-Alzheimer's A beta interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900400-6

10.1016/S0014-5793(97)00400-6

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference